
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES95
At the 52-week follow-up point, the combination of lisinopril and telmisartan showed significantly
greater reductions in both SBP and DBP than the individual monotherapies (p=0.003 for both
SBP and DBP).243 Level 1+

[@Mann_2003]

